AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAY 8 - (NewsRx.com & NewsRx.net) -- When a deer tick bites a human or other mammalian host, it takes more than 24 hours before the Lyme disease bacterium travels from the tick's gut to the tick's salivary glands and then into the host. During that time, bioactive proteins in the tick's saliva begin to suppress the mammal's pain response, increase blood flow to the area, and prevent clotting while at the same time battling the mammal's immune system response to the biting arthropod.
Two University of Rhode Island (URI) researchers believe that the proteins in the tick's saliva may be the key to developing a new vaccine for preventing Lyme disease and other tick-transmitted infections by protecting hosts against blood-feeding ticks. The U.S. National Institutes of Health (NIH) recently awarded them $2.3 million to screen for the most promising tick salivary genes over the next 5 years. URI entomology professor Thomas Mather and microbiology professor David Nelson, director and associate director, respectively, of the URI Center for Vector Borne Disease, discovered the importance of tick saliva as a result of NIH-funded research in the late 1990s. The new grant will help them pinpoint the genes and proteins that can best be developed into a vaccine.
"Ticks have more than 400 proteins in their saliva, many of which have evolved to help them steal blood from a host animal by inactivating specific factors of the immune system," explained Mather. "We're attempting to identify, purify, and learn the function of these various proteins, because by disrupting their function we may be able to prevent ticks from feeding and transmitting disease-causing microbes."
Since they began ...
Source: HighBeam Research, Tick saliva genes key to vaccine.(Brief Article)